Related Experiment Video

Updated: Jun 13, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

All-cause and CVD mortality in Native Hawaiians

N Emmett Aluli1, Phillip W Reyes, S Kalani Brady

  • 1Moloka'i General Hospital, Kaunakakai, Moloka'i, HI, USA.

Diabetes Research and Clinical Practice
|April 16, 2010
PubMed

Insights

Cardiovascular disease (CVD) is a major cause of death for Native Hawaiians, particularly those with diabetes. Managing diabetes, blood pressure, and cholesterol is crucial for reducing CVD mortality in this population.

Area of Science:

  • Public Health
  • Epidemiology
  • Cardiology

Background:

  • Cardiovascular disease (CVD) represents the primary cause of mortality among Native Hawaiians.
  • Understanding CVD prevalence and risk factors within this demographic is critical for targeted health interventions.

Purpose of the Study:

  • To examine all-cause and cardiovascular mortality rates in the Native Hawaiian population.
  • To identify key risk factors associated with cardiovascular disease in this group.

Main Methods:

  • Analysis of data from 855 Native Hawaiians (ages 19-88) participating in the Cardiovascular Risk Clinics program (1992-1998).
  • Mortality surveillance through September 2007, with causes of death determined via medical records, death certificates, and community outreach.

Main Results:

  • Cardiovascular disease accounted for 55% of all deaths, with coronary heart disease (CHD) being the most common type.
  • CVD mortality increased with age and was significantly higher in individuals with diabetes, hypertension, and elevated low-density lipoprotein cholesterol (LDL-C).
  • Diabetes was associated with a fourfold increase in CVD rates, and men exhibited higher CVD rates than women.

Conclusions:

  • Diabetes is a primary determinant of cardiovascular disease in the Native Hawaiian population.
  • A significant proportion of CVD deaths occur in individuals with diabetes.
  • Implementing strategies for diabetes prevention and improved management of hypertension and lipid levels are essential for reducing CVD rates in Native Hawaiians.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...